197 related articles for article (PubMed ID: 32546718)
21. Transmission of canine transmissible venereal tumour between two dogs in the UK.
Hayes AM; Schiavo L; Constantino-Casas F; Desmas I; Dobson J; Draper A; Elliot J; Genain MA; Wang J; Murchison EP
J Small Anim Pract; 2023 Sep; 64(9):590-594. PubMed ID: 36990106
[TBL] [Abstract][Full Text] [Related]
22. [Recent advances in transmissible tumors].
Yin TT; Wang L; Wang GD
Yi Chuan; 2015 Nov; 37(11):1086-94. PubMed ID: 26582522
[TBL] [Abstract][Full Text] [Related]
23. Use of a murine xenograft model for canine transmissible venereal tumor.
Harmelin A; Pinthus JH; Katzir N; Kapon A; Volcani Y; Amariglio EN; Rehavi G
Am J Vet Res; 2001 Jun; 62(6):907-11. PubMed ID: 11400849
[TBL] [Abstract][Full Text] [Related]
24. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors.
Alzate JM; Montoya-Florez LM; Pérez JE; Rocha NS; Pedraza-Ordonez FJ
Vet Clin Pathol; 2019 Dec; 48(4):730-739. PubMed ID: 31777108
[TBL] [Abstract][Full Text] [Related]
25. A retrospective study of canine transmissible venereal tumour in Grenada, West Indies.
Schectman SJ; Khanam A; Walters MND; Kirwan E; Sylvester WR; Khan FA
Vet Med Sci; 2022 May; 8(3):1008-1012. PubMed ID: 35238497
[TBL] [Abstract][Full Text] [Related]
26. Comparison against 186 canid whole-genome sequences reveals survival strategies of an ancient clonally transmissible canine tumor.
Decker B; Davis BW; Rimbault M; Long AH; Karlins E; Jagannathan V; Reiman R; Parker HG; Drögemüller C; Corneveaux JJ; Chapman ES; Trent JM; Leeb T; Huentelman MJ; Wayne RK; Karyadi DM; Ostrander EA
Genome Res; 2015 Nov; 25(11):1646-55. PubMed ID: 26232412
[TBL] [Abstract][Full Text] [Related]
27. Detection of the tumour suppressor gene TP53 and expression of p53, Bcl-2 and p63 proteins in canine transmissible venereal tumour.
Stockmann D; Ferrari HF; Andrade AL; Cardoso TC; Luvizotto MC
Vet Comp Oncol; 2011 Dec; 9(4):251-9. PubMed ID: 22077405
[TBL] [Abstract][Full Text] [Related]
28. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
[TBL] [Abstract][Full Text] [Related]
29. Canine transmissible venereal tumour: a review.
Ganguly B; Das U; Das AK
Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
[TBL] [Abstract][Full Text] [Related]
30. Origins and evolution of a transmissible cancer.
Rebbeck CA; Thomas R; Breen M; Leroi AM; Burt A
Evolution; 2009 Sep; 63(9):2340-9. PubMed ID: 19453727
[TBL] [Abstract][Full Text] [Related]
31. Epidemiological study of canine transmissible venereal tumor (CTVT) in Brazil, 2000-2020.
Pimentel PAB; Oliveira CSF; Horta RS
Prev Vet Med; 2021 Dec; 197():105526. PubMed ID: 34740024
[TBL] [Abstract][Full Text] [Related]
32. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
33. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
Mukaratirwa S; Gruys E
Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
[TBL] [Abstract][Full Text] [Related]
34. Molecular Signatures of Regression of the Canine Transmissible Venereal Tumor.
Frampton D; Schwenzer H; Marino G; Butcher LM; Pollara G; Kriston-Vizi J; Venturini C; Austin R; de Castro KF; Ketteler R; Chain B; Goldstein RA; Weiss RA; Beck S; Fassati A
Cancer Cell; 2018 Apr; 33(4):620-633.e6. PubMed ID: 29634949
[TBL] [Abstract][Full Text] [Related]
35. Transmissible Cancers and Immune Downregulation in Tasmanian Devil (
Chale RS; Ghiam N; McNamara SA; Jimenez JJ
Comp Med; 2019 Aug; 69(4):291-298. PubMed ID: 31387668
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and Management of an Oronasal Fistula Secondary to Nasal Transmissible Venereal Tumor in a Dog.
Thatcher G; Robat C; Bell C
J Vet Dent; 2020 Dec; 37(4):220-226. PubMed ID: 33719713
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic and molecular profile of cancer stem-cell markers in ex vivo canine transmissible venereal tumour (CTVT).
Grandi F; Miot HA; Rocha RM; Gomes CMS; Queiroz-Hazarbassanov N; Montoya-Florez LM; Cogliati B; Rocha NS
Vet Med Sci; 2022 Nov; 8(6):2297-2306. PubMed ID: 36098244
[TBL] [Abstract][Full Text] [Related]
38. Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya.
Hiblu MA; Khabuli NM; Gaja AO
Open Vet J; 2019 Jul; 9(2):103-105. PubMed ID: 31360646
[TBL] [Abstract][Full Text] [Related]
39. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells.
Hsiao YW; Liao KW; Hung SW; Chu RM
Vet Immunol Immunopathol; 2002 Aug; 87(1-2):19-27. PubMed ID: 12052339
[TBL] [Abstract][Full Text] [Related]
40. Computer tomographic imaging in 4 dogs with primary nasal canine transmissible venereal tumor and differing cellular phenotype.
Ojeda J; Mieres M; Soto F; Arnes V; Paredes E; Navarrete M
J Vet Intern Med; 2018 May; 32(3):1172-1177. PubMed ID: 29604101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
